jueves, 7 de marzo de 2019

NIAID Now | NIH: National Institute of Allergy and Infectious Diseases

NIAID Now | NIH: National Institute of Allergy and Infectious Diseases

NIH: National Institute of Allergy and Infectious Diseases

March 6, 2019
Even when HIV is well-controlled with antiretroviral therapy, the virus can cause persistent immune activation that contributes to an increased risk of complications such as heart disease and certain cancers. New NIAID-supported research presented today at CROI 2019 in Seattle sheds light on the relationship between immune activation and weight gain.

No hay comentarios:

Publicar un comentario